UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

Hubungan Kadar Carcinoembryonic Antigen (CEA), Kadar Hemoglobin, dan Nilai Neutrophil to Lymphocyte Ratio (NLR) Dengan Indikator Derajat Diferensiasi Histopatologi Pada Pasien Kanker Kolorektal

dc.contributor.authorInnanda, Muhammad Zidane
dc.contributor.otherYulia, Dwi
dc.contributor.otherSuchitra, Avit
dc.date.accessioned2026-09-24T17:56:32Z
dc.date.issued2025-12-19
dc.descriptionDr. dr. Dwi Yulia, Sp.PK, Subsp.Onk.K (K); Dr. dr. Avit Suchitra, Sp.B, Subsp.BD (K)
dc.description.abstractKanker kolorektal menjadi masalah kesehatan global dengan angka insiden dan mortalitas yang signifikan. Identifikasi karakteristik klinis menggunakan biomarker tumor dan parameter hematologi menjadi aspek yang sangat penting dalam mengevaluasi derajat diferensiasi sel tumor. Penelitian ini bertujuan mengetahui karakteristik kadar Carcinoembryonic Antigen (CEA), hemoglobin, serta nilai Neutrophil to Lymphocyte Ratio (NLR) sebagai indikator derajat diferensiasi histopatologi pasien kanker kolorektal. Penelitian ini merupakan studi observasional analitik dengan pendekatan retrospektif menggunakan data rekam medis pasien di RS Dr. M. Djamil Padang periode Januari 2023 hingga Desember 2024. Sampel berjumlah 154 pasien yang memenuhi kriteria inklusi dan eksklusi diambil dengan teknik total sampling. Data dianalisis menggunakan uji statistik untuk menilai signifikansi hubungan antar variabel. Distribusi pasien berjenis kelamin perempuan lebih banyak (55,8%) dan lebih dari separuh berusia di atas 50 tahun (62,3%). Gambaran histopatologi sebagian besar berderajat low grade (81,2%). Hasil uji statistik menunjukkan terdapat hubungan yang bermakna antara kadar CEA dengan derajat diferensiasi histopatologi (p=0,017). Namun, tidak ditemukan hubungan yang bermakna secara statistik antara kadar hemoglobin (p=0,822) maupun nilai NLR (p=0,303) dengan derajat diferensiasi histopatologi. Terdapat hubungan signifikan antara kadar CEA dengan derajat diferensiasi histopatologi, sedangkan kadar hemoglobin dan nilai NLR tidak menunjukkan hubungan yang signifikan. Kadar CEA dapat menjadi indikator potensial dalam memprediksi derajat diferensiasi tumor pada pasien kanker kolorektal.
dc.identifier.urihttps://ailib.my.id/handle/123456789/8517
dc.language.isoid
dc.publisherUniversitas Andalas
dc.subjectKanker kolorektal
dc.subjectCEA
dc.subjecthemoglobin
dc.subjectNLR
dc.subjectderajat diferensiasi
dc.subject.classificationR Medicine (General)
dc.subject.classificationRB Pathology
dc.subject.classificationRC0254 Neoplasms. Tumors. Oncology (including Cancer)
dc.subject.classificationRD Surgery
dc.titleHubungan Kadar Carcinoembryonic Antigen (CEA), Kadar Hemoglobin, dan Nilai Neutrophil to Lymphocyte Ratio (NLR) Dengan Indikator Derajat Diferensiasi Histopatologi Pada Pasien Kanker Kolorektal
dc.typeThesis
dcterms.dateSubmitted2026-01-09
dcterms.referencesSung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–49. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Vol. 14, Translational Oncology. Neoplasia Press, Inc.; 2021. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020 Jul 1;159(1):335-349.e15. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7–33. Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Vol. 19, Nature Reviews Clinical Oncology. Springer Nature; 2022. p. 656–73. Abdullah M, Meilany S, Trimarsanto H, Malik SG, Sukartini N, Idrus F, et al. Genomic profiles of Indonesian colorectal cancer patients. F1000Res. 2022 Apr 20;11:443. Purnomo HD, Permatadewi CO, Prasetyo A, Indiarso D, Hutami HT, Puspasari D, et al. Colorectal cancer screening in Semarang, Indonesia: A multicenter primary health care based study. PLoS One. 2023 Jan 1;18. Kumar V, Abbas A, Aster J, Turner J. Robbins & Cotran Pathologic Basis of Disease Tenth Edition. Elsevier. 2021. Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Vol. 13, Cancers. 2021. Marcellinaro R, Spoletini D, Grieco M, Avella P, Cappuccio M, Troiano R, et al. Colorectal Cancer: Current Updates and Future Perspectives. Vol. 13, Journal of Clinical Medicine. Multidisciplinary Digital Publishing Institute (MDPI); 2024. Kankanala VL, Zubair M, Mukkamalla SKR. Carcinoembryonic Antigen. StatPearls [Internet]. 2024 Dec 11 [cited 2025 Apr 27]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK578172/ Shabo I, Nordling E, Abraham-Nordling M. Artificial intelligence prediction of carcinoembryonic antigen structure and interactions relevant for colorectal cancer. Biochem Biophys Rep. 2025 Jun 1;42. Zhang C, Zheng W, Lv Y, Shan L, Xu D, Pan Y, et al. Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels. Transl Cancer Res. 2020 Jan 1;9(1):111–8. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Vol. 76, Histopathology. Blackwell Publishing Ltd; 2020. p. 182–8. Asprilia R, Efrida, Syofiati. Differences in Carcinoembryonic Antigen (CEA) Levels Based on the Degree of Histopathological Differentiation of Colorectal Cancer: Single Center Observational Study at Dr. M. Djamil General Hospital, Padang, Indonesia. Bioscientia Medicina : Journal of Biomedicine and Translational Research. 2024 May 29;8(8):4789–95. Mohammad F, Muhar AM, Siregar ES. Association Between Recurrence Rates of Colorectal Cancer and Carcinoembryonic Antigen Levels, Histopathological Features, Tumor-Infiltrating Lymphocytes, and Lymphatic Invasion at H. Adam Malik Central General Hospital, Medan. 2024. Joseph L, Anthony F, Dennis K, Stephen H, Longo, J.Larry J. Harrison’s Principles of Internal Medicine, Twenty-First Edition. 21th ed. Vol. 1, Harrison’s Principles of Internal Medicine. McGraw-Hill Education / Medical; 2022. Hamid HKS, Davis GN, Trejo-Avila M, Igwe PO, Garcia-Marín A. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis. Vol. 37, Surgical Oncology. Elsevier Ltd; 2021. Widhyasih RM, Rahmadhanti SD, Fajrunni’mah R. Carcinoembryonic Antigen (CEA) dan Neutrofil-to-Limfosit Ratio (NLR) sebagai Faktor Prediktif Kanker Kolorektal Artikel history. Jurnal Ilmu Dan Teknologi Kesehatan. 2021;7(1):2338–9095. Iskandar M, Tendean M, Salem B, Langi FG. Korelasi antara Neutrophil-to-Lymphocyte Ratio dan Kadar Carcinoembryonic Antigen Pra-Pasca Operasi pada Kanker Kolorektal. Medical Scope Journal. 2023 Aug 27;5(2):270–8. Simatupang RV, Katharine, Sinaga BYM, Abdillah HZ. Profil Hemoglobin, Trombosit, dan Rasio Neutrofil Limfosit pada Pasien Kanker Kolorektal: Studi Deskriptif di RSUP Haji Adam Malik Medan. Jurnal Kedokteran Meditek. 2025 Oct 6;31(5). Surveillance, Epidemiology, and End Results Program [Internet]. [cited 2025 Apr 26]. Available from: https://seer.cancer.gov/ Amin MB, Edge SB, Greene FL, Schilsky RL, Brookland RK, Washington MK, et al. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. AJCC Cancer Staging Manual. 2017. Keung EZ, Gershenwald JE. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Vol. 18, Expert Review of Anticancer Therapy. Taylor and Francis Ltd; 2018. p. 775–84. Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, et al. Diagnosis of digestive system tumours. Vol. 148, International Journal of Cancer. Wiley-Liss Inc.; 2021. p. 1040–50. Huang L, Li Z, Jian M, Wu X, Chen H, Qin H, et al. Application of MFI-5 in severe complications and unfavorable outcomes after radical resection of colorectal cancer. World J Surg Oncol. 2023 Dec 1;21(1). Morimoto Y, Takahashi H, Arita A, Itakura H, Fujii M, Sekido Y, et al. High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer. Oncol Lett. 2021 May 1;23(5). Jia J, Li M, Teng W, Wang L, Zang W, Xiao J, et al. Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer. J Oncol. 2021;2021. Xie H, Wei L, Liu M, Liang Y, Wang Q, Tang S, et al. The value of carcinoembryonic antigen stage in staging, prognosis, and management of colorectal cancer: results from two cohort studies. Front Oncol. 2023;13. Kim HR, Joo J Il, Lim SW, Oh BY. Prognostic value of carcinoembryonic antigen levels before and after curative surgery in colon cancer patients. Ann Surg Treat Res. 2021 Jan 1;100(1):33–9. Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen PL, Joensuu H, Hermunen K, Soveri LM, et al. Lead time and prognostic role of serum CEA, CA19-9, IL-6, crp, and YKL-40 after adjuvant chemotherapy in colorectal cancer. Cancers (Basel). 2021 Aug 1;13(15). Gao Y, Wang J, Zhou Y, Sheng S, Qian SY, Huo X. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Sci Rep. 2018 Dec 1;8(1). Alsiary RA, Abdullah K. CEA and CA19-9 Levels and KRAS Mutation Status as Biomarkers for Colorectal Cancer [Internet]. Remedy Publications LLC. 2021. Available from: http://clinicsinoncology.com/ Su BB, Shi H, Wan J. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. World J Gastroenterol. 2022;18(17):2121–6. Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L, et al. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Vol. 134, International Journal of Cancer. Wiley-Liss Inc.; 2014. p. 2513–22. Lakemeyer L, Sander S, Wittau M, Henne-Bruns D, Kornmann M, Lemke J. Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer. Diseases. 2021 Mar 1;9(1). Luo H, Shen K, Li B, Li R, Wang Z, Xie Z. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer. Oncol Lett. 2020 Jul 1;20(1):742–50. Agusrly C, Sungkar T, Siregar GA. Relationship Between Staging and Carcinoembryonic Antigen Serum Levels In Colorectal Cancer Patients’. Journal of Endocrinology, Tropical Medicine, and Infectiouse Disease (JETROMI). 2020 Aug 28;2(3):118–23. Wang H, Chen H, Fu Y, Liu M, Zhang J, Han S, et al. Effects of Smoking on Inflammatory-Related Cytokine Levels in Human Serum. Molecules. 2022 Jun 1;27(12). Can Trabulus D, Duraker N, Civelek Çaynak Z. The Prognostic Value of Preoperative Serum Levels of CEA and CA 19-9 in Patients with Colorectal Cancer. Turkish Journal of Colorectal Disease. 2022 Jun 24;32(2):103–9. Rudiman R, Lukman K, Barr TI. Correlation Between Tumor Cell Differentiation and CEA Levels in Patients with Adenocarcinoma of the Rectum. Majalah Kedokteran Bandung. 2020 Dec;52(4). Ratmayanti MAL, Sueta MAD, Sudartana IK. Stage, Grade, and Pre-Operative Red Cell Distribution Width (RDW) Associated with Mortality of Colorectal Cancer Patients at Prof. Dr. I.G.N.G Ngoerah Hospital, Bali. Indonesian Journal of Cancer. 2025 Jun 30;19(2):289–96. American Cancer Society. Colorectal Cancer Facts & Figures 2020-2022. Atlanta; 2023. Lukman K, Muhammad A, Ghozali M, Nugraha P, Sribudiani Y, Nursabur BM. Epidemiological and Clinicopathological Characteristics of Colorectal Cancer Patients in Tertiary Hospital in West Java. Clin Epidemiol Glob Health. 2024 Jul 1;28. Yayin HE, Bektas S, Gonullu D, Basat Okcan. The relationship between preoperative CA 19-9 and CEA levels and histopathology of tumor in colorectal cancer. Journal of Contemporary Medicine. 2023 May 31;13(3):534–9. Naicker YD, Moolla Z, Madiba T. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of kwazulu-natal, South Africa. Pan African Medical Journal. 2021;39. Sihotang S, Putranto AS. Serum CEA Level in Predicting Liver Metastases of Colorectal Cancer Among Young Adult Patients. The New Ropanasuri Journal of Surgery. 2022 Jun 26;7(1). Gramkow MH, Mosgaard CS, Schou J V., Nordvig EH, Dolin TG, Lykke J, et al. The prognostic role of circulating CA19–9 and CEA in patients with colorectal cancer. Cancer Treat Res Commun. 2025 Jan 1;43. Linailil U, Vito ME, Eko S, Chodidjah, Siti TZ. Pengaruh Pemberian Kemoterapi Neoadjuvant Terhadap Kadar CEA dan Survival: Studi Observasional Analitik pada Pasien Kanker Rektum Stadium III di Rumah Sakit Islam Sultan Agung Semarang Periode 2018-2023. 2024 Dec 3;1:59–75. Allahyari A, Fallah F, Bahrami Taqanaki P, Pouria Tafti S, Vakilzadeh MM, Moeini Nodeh M, et al. Evaluating the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic and treatment response biomarkers in stage IV colorectal cancer patients. Oncology in Clinical Practice. 2025 Jun 28;21(3):200–5. Krishnamoorthy A, Arasaradnam R. Colorectal cancer diagnostic biomarkers: Beyond faecal haemoglobin. Vol. 66, Best Practice and Research: Clinical Gastroenterology. Bailliere Tindall Ltd; 2023. Chang CH, Weng HH, Lin YC, Lin CN, Huang TJ, Chen MY. Association between serum carcinoembryonic antigen and cardiometabolic risks: Implication for cardiometabolic prevention. Front Endocrinol (Lausanne). 2023;14. Chardalias L, Papaconstantinou I, Gklavas A, Politou M, Theodosopoulos T. Iron Deficiency Anemia in Colorectal Cancer Patients: Is Preoperative Intravenous Iron Infusion Indicated? A Narrative Review of the Literature. Vol. 3, Cancer Diagnosis and Prognosis. International Institute of Anticancer Research; 2023. p. 163–8. Deng Y, Weng M, zhang J. Preoperative anemia and long-term survival in patients undergoing colorectal cancer surgery: a retrospective cohort study. World J Surg Oncol. 2023 Dec 1;21(1). Gvirtzman R, Livovsky DM, Tahover E, Goldin E, Koslowsky B. Anemia can predict the prognosis of colorectal cancer in the pre-operative stage: a retrospective analysis. World J Surg Oncol. 2021 Dec 1;19(1). Purnomo H, Handaya Y, Setyawan N. Neutrophil to Hemoglobin Lymphocyte Ratio (NHLR) as a Novel Biomarker is Superior to Neutrophil Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) as Predictors of Advanced Colorectal Cancer. Indonesian Journal of Cancer. 2024 Mar 27;18(1):47–52. Rajabto W, Tridana Sakti P, Putra Kevinsyah A. Iron Deficiency Anemia as The Only Manifestation of Colon Cancer in Male Patient: A Case Report. Vol. 21. 2020. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislava Medical Journal. 2021;122(7):474–88. Fridlender ZG, Granot Z. Neutrophils in the tumor microenvironment – when a company becomes a crowd. Vol. 21, Cellular and Molecular Immunology. Springer Nature; 2024. p. 313–4. Gawiński C, Mróz A, Roszkowska-Purska K, Sosnowska I, Derezińska-Wołek E, Michalski W, et al. A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer. Biomedicines. 2023 Nov 1;11(11). Li Y, Xu T, Wang X, Jia X, Ren M, Wang X. The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis. Vol. 23, Cancer Cell International. BioMed Central Ltd; 2023. Xu L, Chen J, Guo H, Huang R, Guo L, Yu Y, et al. Distribution of peripheral blood cells in esophageal cancer patients during concurrent chemoradiotherapy predicts long-term locoregional progression hazard after treatment (Gasto1072). Cancer Manag Res. 2021;13:4203–15. Prabawa IPY, Bhargah A, Liwang F, Tandio DA, Tandio AL, Lestari AAW, et al. Pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a predictive value of hematological markers in cervical cancer. Asian Pacific Journal of Cancer Prevention. 2019;20(3):863–8. Kim JH, Lee JY, Kim HK, Lee JW, Jung SG, Jung K, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol. 2017 Jan 21;23(3):505–15. Dewi DAM, Setyawan UA, Karliasari L. Neutrophil-Lymphocyte Ratio (NLR) as a Prognostic Marker in Advanced Lung Cancer Patients Undergoing First-Line Treatment. Jurnal Respirasi. 2024 Sep 30;10(3):209–13. Liana N, Hilbertina N, Devianti L, Yetti H. Hubungan Ekspresi Vascular Endothelial Growth Factor (VEGF) Terakreditasi KEMENRISTEKDIKTI/Sinta-3 Maj Patol Indones 2022. 31(1):368–75. Aden KAT, Mulyani H, Suchitra A, Hilbertina N, Nurhayati N. Analisis Karakteristik Klinikopatologi Kanker Kolorektal di Laboratorium Patologi Anatomi RSUP Dr. M. Djamil 2020-2022. Jurnal Penelitian Sains. 2025 Apr 30;27(1):1. Hasan MF, Hilbertina N, Deddy S. Karakteristik Klinikopatologi Kanker Kolorektal di Laboratorium Patologi Anatomi RSUP Dr. M. Djamil Padang Tahun 2017-2020. Repositori Universitas Andalas. 2022 Feb 4;27–36. Nugrahani RW, Rahniayu A, Mastutik G. Profile of Colorectal Adenocarcinoma in Dr. Soetomo Hospital Surabaya Period 2018-2022. International Journal Of Scientific Advances. 2024;5(5). Vienna AL, Indra W, Devia EL, Udadi S, Puspasari D. Hubungan Ekspresi HER2 dan Galectin-3 dengan Gambaran Klinikopatologis Adenokarsinoma Kolorektal. Jurnal Kedokteran Raflesia. 2020;6(2):3778–2477. Ramadhan RS. Korelasi Positif antara Tumor Associated Macrophage dengan Stadium Klinis pada Adenokarsinoma Kolorektal. Majalah Kedokteran Andalas. 2024 Mar 14;46(3):578–91. Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆. Annals of Oncology. 2023 Jan 1;34(1):10–32. Labeda I, Lusikooy RE, Mappincara, Dani MI, Sampetoding S, Kusuma MI, et al. Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study. Annals of Medicine and Surgery. 2022 Feb 1;74. Huang X, Nie F, Zhu J, Liu L, Wang N. Diagnostic Value of Contrast-Enhanced Ultrasound Features for WHO/ISUP Grading in Renal Cell Carcinoma. Journal of Ultrasound in Medicine. 2023;42(7). Kamada T, Ohdaira H, Takahashi J, Aida T, Nakashima K, Ito E, et al. Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer. Sci Rep. 2024 Dec 1;14(1). Sutrisno, Jennah AY, Puspita EA. Hubungan Usia dan Jenis Kelamin dengan Stadium Kanker Kolorectal di RSUD Dr Soegiri Lamongan. Surabaya; 2025 Feb. Husnah A, Yanti AK, Arifin AF, Hasbi BE, Ikram D. Karakteristik Penderita Kanker Kolorektal Di Rumah Sakit Pendidikan Ibnu Sina Makassar Tahun 2022. Makassar; 2024 Jan. Makmun D, Simadibrata M, Abdullah M, Syam AF, Shatri H, Fauzi A, et al. Retrospective Study Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors. World J Clin Cases. 2021 Nov 16;9(32):9804–14. Widya A, Siswandi A, Wulandari M, Kumala I. Karakteristik pasien kanker kolorektal stadium I-IV di Rumah Sakit Umum Daerah Dr. H. Abdul Moeloek. Jurnal Ilmu Kedokteran dan Kesehatan. 2023 Jul;10(7):2360–74. Satriyo CB, Susanto H, Handaya AY, Setiawan N, Sofii I, Barmawi A. Differences of alt-ast level and snail gene expression between patients with metastasis and non-metastasis colorectal cancer. Jurnal Kedokteran dan Kesehatan Indonesia. 2022 Dec 5;251–62.
local.eprints.dirdisk0/00/51/64/74
local.eprints.divisionS1KEDOK2024
local.eprints.id516474
local.eprints.typethesis/2Sarjana
local.eprints.urihttp://scholar.unand.ac.id/516474/
local.fakultasFakultas Kedokteran
local.identifier.nim2210311021
local.prodiS1 Kedokteran
local.thesis.levelSkripsi

Files

Collections